Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search


New Milestones In Diabetes Treatment

New Milestones In Diabetes Treatment And Understanding Announced At Scientific Congress In Christchurch

Christchurch, New Zealand, Wednesday, 29 August 2001 - Two new milestones in the treatment and prevention of diabetes have been announced at the 34th International Congress of Physiological Sciences, New Zealand's largest ever scientific gathering, being held in Christchurch this week. Garth Cooper, Professor of Biochemistry in the School of Biological Sciences at the University of Auckland, said the discoveries would help alleviate the suffering of thousands of New Zealanders and others around the world with Type 1 and Type 2 diabetes.

Professor Cooper yesterday announced to Congress delegates the discovery of a new mechanism by which insulin-producing cells in the pancreas are destroyed - a major cause of Type 2 diabetes. The knowledge is expected to open up new avenues for the prevention and suppression of this type of diabetes.

"This is a major discovery that has given us a new understanding of how Type 2 diabetes develops over time. Our hope is that this knowledge will enable us to pursue new methods and techniques to prevent the destruction of the body's insulin production system," he said. "Progress like this gives us the motivation to continue doing our research, pursuing successful treatments that combat widespread diseases like diabetes."

Professor Cooper also said that a major step forward in another treatment for diabetes had been achieved over the past week, with the successful final clinical trials of the therapeutic version of the hormone Amylin. This has been found to be effective by the Federal Drug Administration in the United States. Professor Cooper said the drug, based on the hormone that he discovered 15 years ago, was expected to be made available for use by insulin requiring diabetics within the next 12 months.

"It has been a long road, but we are delighted that the drug has been proven and is likely to be available for those suffering with diabetes in the very near future," said Professor Cooper.


© Scoop Media

Business Headlines | Sci-Tech Headlines


Media Mega Merger: StuffMe Hearing Argues Over Moveable Feast

New Zealand's two largest news publishers are appealing against the Commerce Commission's rejection of the proposal to merge their operations. More>>


Approval: Northern Corridor Decision Released

The approval gives the green light to construction of the last link of Auckland’s Western Ring Route, providing an alternative route from South Auckland to the North Shore. More>>


Crown Accounts: $4.1 Billion Surplus

The New Zealand Government has achieved its third fiscal surplus in a row with the Crown accounts for the year ended 30 June 2017 showing an OBEGAL surplus of $4.1 billion, $2.2 billion stronger than last year, Finance Minister Steven Joyce says. More>>


Mycoplasma Bovis: One New Property Tests Positive

The newly identified property... was already under a Restricted Place notice under the Biosecurity Act. More>>

Accounting Scandal: Suspension Of Fuji Xerox From All-Of-Government Contract

General Manager of New Zealand Government Procurement John Ivil says, “FXNZ has been formally suspended from the Print Technology and Associated Services (PTAS) contract and terminated from the Office Supplies contract.” More>>